Pediatrics

More than 30 new drugs have been approved for pediatric cancer in the past 10 years, but progress has not benefited all patients

Recent findings from scientists at St. Jude Children’s Research Hospital are showing promise for assessing cardiomyopathy risk in childhood cancer survivors

Researchers at St. Jude Children’s Research Hospital have created a cost-effective, easy-to-use test to categorize a child’s cancer and guide better treatment

Incorporating drug screening and genomic analyses may help finetune precision medicine approaches taken in pediatric cancers 

Findings revealed the efficacy of anti-TNF inhibitors monotherapy versus combination therapy with anti-TNF inhibitors and immunosuppressants

Clinical recommendations to help assess and prevent heart diseases in pediatric patients

Treatment of childhood-onset hearing loss can be more precisely tailored with information on specific genetic cause

A six-year study finds that adopting pediatric readiness standards lowers the chance of dying in emergency departments

Researchers have now comprehensively studied the pharmacogenomics of ALL revealing a wide variability

NIH-supported study finds no serious complications following rare immune condition